- Home
- Products
- Customized FluoroAb™
- C5
- Pexelizumab-iFluor 568
Pexelizumab-iFluor 568 (CAT#: ADC-FL-259)
This product is comprised of an anti-C5 scFv antibody (Pexelizumab) labeled with iFluor 568. iFluor 568 is a orange-fluorescent dye and it's excitation/emission is 578/603 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- C5
- Alternative Names
- C5; complement component 5; complement C5; CPAMD4; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; FLJ17816; FLJ17822; MGC142298;
- Overview
- This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
- Overview
- Humanized Anti-C5 scFv antibody, Pexelizumab
- Generic name
- Pexelizumab
- Species Reactivity
- Human
- Name
- iFluor 568
- Color
- Orange
- Excitation⁄Emission (nm)
- 578/603
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-ITGB2 MAb (Clone 8)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5994)
- Anti-EGFR MAb (Clone 18)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8534)
- Anti-TNFRSF17 MAb (Clone 10)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15759)
- Anti-SLAMF6 MAb (Clone 2)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14234)
- Anti-CD4 MAb (Clone 9)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8832)
- Anti-ANGPT2 MAb (Clone 5)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7229)
- Anti-IGHE MAb (Clone 10)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15144)
- Anti-TNF MAb (Clone 19)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4596)
- Anti-MS4A1 MAb (Clone 7)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12962)
- Anti-CD4 MAb (Clone 37)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7322)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-259. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-728 | Anti-C5 (Eculizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-737 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-734 | Anti-C5 (Pexelizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-732 | Anti-C5 (Eculizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-738 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
